Information for investors including Annual Reports, Financial Calendar, Shareholders' Information and Quarterly Trading Result.
Investing in GSK
Our business is focused around the delivery of three strategic priorities which aim to increase growth, reduce risk and improve our long-term financial performance. These priorities are: grow a balanced global business, deliver more products of value, and simplify the operating model. Operating responsibly and ensuring our values are embedded in our culture and decision-making helps us better meet the expectations of society.
Grow a balanced business
We have been creating a more balanced business and product portfolio, capable of delivering sustainable sales and earnings growth and improved returns to shareholders.
This is centred on our three business areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
Deliver more products of value
We have changed our R&D organisation so that it is better able to sustain a pipeline of products that offer valuable improvements in treatment for patients and healthcare providers. This is underpinned by a focus on improving productivity and rates of return in R&D.
Simplify the operating model
As our business continues to change shape, we are transforming how we operate so that we can reduce complexity and become more efficient. This frees up resources to reinvest elsewhere in the business, or return to shareholders wherever we see the most attractive returns.
Being a responsible business is central to our strategy, and how we deliver success is just as important as what we achieve. Ensuring our values are embedded in our culture and decision-making helps us better meet the expectations of society.
General Meetings & Annual Reports
Information for shareholders including Notices, Annual Reports and Quarterly Trading Result
Scheduled timeline for the release of Financial Results
|Audited Financial Statement||March|
|Quarter 1 Un-audited Results||April|
|Quarter 2 Un-audited Results||July|
|Quarter 3 Un-audited Results||October|
Shareholder InformationShareholder Information PDF - 210.0KB Bonus History PDF - 181.2KB Ten Year Dividend History PDF - 293.4KB
Investors and Analysts
Investors and Analysts should contact :
Individual Shareholders should contact:
Registrars and Transfer Office
Akintola Williams Deloitte
Civic Towers Ozumba Mbadiwe Road
Tel: +234 -1-2717800
Find out more about us
Policies, Codes and Standards
Find out more about the GSK Code of Conduct and our Anti-Bribery and Corruption program
Board of Directors
The Board of Directors is responsible for the company's system of corporate governance and is ultimately accountable for the company's activities, strategy, risk management and financial performance.
Our Management teams assist the managing directors in managing both businesses. Find out about its members and their responsibilities.